Capula Management LTD Edwards Lifesciences Corp Call Options Transaction History

Capula Management LTD

4 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q1 2021 May 14, 2021	SELL	$78.68 - $90.67 $7.58 Million - $8.73 Million	-96,300 Reduced 81.89%	21,300 $1.78 Million
Q4 2020 Feb 16, 2021	BUY	$71.69 - $91.23 $8.43 Million - $10.7 Million	117,600 New	117,600 $10.7 Million
Q4 2019 Feb 14, 2020	SELL	$71.7 - $82.09 $100,380 - $114,926	-1,400 Closed	0 $0
Q3 2019 Nov 14, 2019	BUY	$61.55 - $75.43 $86,170 - $105,602	1,400 New	1,400 $308,000

1,417

469M

2.44M

2.65M

Ticker EW
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 618,259,968
Market Cap $40.5B
Description
Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...

Get notified when there are updates to the investment portfolio of Capula Management LTD, based on Form 13F filings with the SEC.

Stay updated on Capula Management LTD with notifications on news.